0001415889-24-017526.txt : 20240618
0001415889-24-017526.hdr.sgml : 20240618
20240618210118
ACCESSION NUMBER: 0001415889-24-017526
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240613
FILED AS OF DATE: 20240618
DATE AS OF CHANGE: 20240618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Boylan James P
CENTRAL INDEX KEY: 0001953094
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39580
FILM NUMBER: 241053779
MAIL ADDRESS:
STREET 1: C/O ENAVATE SCIENCES
STREET 2: 2884 SAND HILL RD., STE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immunome Inc.
CENTRAL INDEX KEY: 0001472012
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 770694340
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18702 N. CREEK PARKWAY
STREET 2: SUITE 100
CITY: BOTHELL
STATE: WA
ZIP: 98011
BUSINESS PHONE: 610-321-3700
MAIL ADDRESS:
STREET 1: 18702 N. CREEK PARKWAY
STREET 2: SUITE 100
CITY: BOTHELL
STATE: WA
ZIP: 98011
4
1
form4-06192024_010614.xml
X0508
4
2024-06-13
0001472012
Immunome Inc.
IMNM
0001953094
Boylan James P
C/O IMMUNOME, INC.
18702 N. CREEK PARKWAY, SUITE 100
BOTHELL
WA
98011
true
false
false
false
0
Stock option (right to buy)
16.04
2024-06-13
4
A
0
11333
0
A
2034-06-12
Common Stock
11333
11333
D
Mr. Boylan has agreed to receive and hold for the benefit of Enavate Sciences, LP, any securities granted to him for his service as a director on the Company's board of directors. As such, Mr. Boylan disclaims beneficial ownership of, and all right, title and interest in, the reported securities.
The options vest in 4 quarterly installments, commencing from June 13, 2024 until the one year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to continued service with the Company on each respective vesting date.
/s/ Sandra Stoneman, Attorney-in-Fact
2024-06-18